ReviewFrontiers in immunology2026

The glycolysis-lactylation axis: a metabolic-epigenetic driver of immunosuppression and therapy resistance in cancer.

Simin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.